4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Co-Diagnostics, Inc. (CODX) operates in the Medical Devices industry and is headquartered in Salt Lake City, United States with about 115 employees. Its market capitalization is roughly $9 million. In the fiscal year ended 2025-12-31, CODX reported $1M in revenue and ($47M) in net income.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
Interactive charts & full statements → Open the CODX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $1M | $4M | $7M | $34M |
| Gross Profit | $0M | $3M | $3M | $29M |
| Operating Income (EBIT) | ($31M) | ($40M) | ($43M) | ($12M) |
| Net Income | ($47M) | ($38M) | ($35M) | ($14M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($9M) | ($8M) | ($7M) | ($8M) | ($9M) | — |
| Net Income | ($9M) | ($26M) | ($6M) | ($8M) | ($8M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $25M | $64M | $95M | $123M | — |
| Total Liabilities | $4M | $10M | $9M | $9M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CODX viewer.
About TickerBase · Data methodology & sources